financetom
Business
financetom
/
Business
/
Calix Fiscal Q3 Non-GAAP Earnings, Revenue Decline; Sets Q4 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Calix Fiscal Q3 Non-GAAP Earnings, Revenue Decline; Sets Q4 Guidance
Nov 3, 2024 1:15 PM

05:48 PM EDT, 10/28/2024 (MT Newswires) -- Calix (CALX) reported fiscal Q3 non-GAAP earnings late Monday of $0.13 per diluted share, down from $0.45 a year earlier.

Analysts polled by Capital IQ expected $0.09.

Revenue for the quarter ended Sept. 28 was $200.9 million, down from $263.8 million a year earlier.

Analysts surveyed by Capital IQ expected $201.1 million.

The company expects Q4 non-GAAP diluted EPS between $0.04 and $0.10 and revenue between $201 million and $207 million.

Analysts polled by Capital IQ expect $0.09 and $203.8 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jacobs Solutions to Design Phase 2 Expansion of Hamilton, Ontario, Wastewater Plant
Jacobs Solutions to Design Phase 2 Expansion of Hamilton, Ontario, Wastewater Plant
May 30, 2024
08:56 AM EDT, 05/30/2024 (MT Newswires) -- Jacobs Solutions ( J ) said Thursday it has been contracted by the City of Hamilton, Ontario, to provide engineering services for the Woodward Avenue Wastewater Treatment Plant Phase 2 Expansion. The $310 million project, part of the city's Clean Harbour Program, is slated for completion by 2032. The expansion will boost the...
Chorus Aviation's Jazz Unit Invests in Emissions Reduction Initiative
Chorus Aviation's Jazz Unit Invests in Emissions Reduction Initiative
May 30, 2024
09:05 AM EDT, 05/30/2024 (MT Newswires) -- Chorus Aviation Inc. ( CHRRF ) subsidiary Jazz Aviation LP on Thursday announced an agreement with France-based, Expliseat, a manufacturer of ultra-light aircraft seats with a focus on sustainability, durability, and passenger comfort. A statement noted this agreement is part of a $10 million investment in Jazz's Air Canada Express cabin modernization for...
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab
May 30, 2024
09:07 AM EDT, 05/30/2024 (MT Newswires) -- Willow Biosciences ( CANSF ) , a biotechnology company, said Thursday that it signed a multi-product development and licensing partnership with Laurus Labs, a research-driven pharmaceutical and biotechnology company. Under the partnership, Willow will deliver biobased processes for high-value Active Pharmaceutical Ingredients with existing markets, including Willow's BioOxi-based corticosteroid processes, for large-scale manufacturing,...
FDA Grants Candel Therapeutics' CAN-3110 Orphan Drug Designation to Treat Recurrent High-Grade Glioma
FDA Grants Candel Therapeutics' CAN-3110 Orphan Drug Designation to Treat Recurrent High-Grade Glioma
May 30, 2024
09:01 AM EDT, 05/30/2024 (MT Newswires) -- Candel Therapeutics ( CADL ) said Thursday that the US Food and Drug Administration has granted orphan drug designation to CAN-3110 to treat recurrent high-grade glioma. The orphan drug designation for CAN-3110 further reinforces the potential of this therapy and underscores the urgent need for novel and effective treatments for patients with rHGG,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved